{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:27:21Z","timestamp":1759847241118},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1007\/s11940-001-0013-x","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T18:14:20Z","timestamp":1180980860000},"page":"507-518","source":"Crossref","is-referenced-by-count":21,"title":["Diffuse lewy body disease"],"prefix":"10.1007","volume":"3","author":[{"given":"Theresa A.","family":"Zesiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"13_CR1","first-page":"66","volume-title":"An Essay on the Shaking Palsy","author":"J Parkinson","year":"1817","unstructured":"Parkinson J: An Essay on the Shaking Palsy. London: Sherwood, Neely & Jones; 1817:66."},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1212\/WNL.53.5.902","volume":"53","author":"IG McKeith","year":"1999","unstructured":"McKeith IG, Perry EK, Perry RH: Diagnosis and treatment of dementia with Lewy bodies (DLB): report of the second DLB International Workshop. Neurology 1999, 53:902\u2013905. A good article on Lewy body disease.","journal-title":"Neurology"},{"key":"13_CR3","first-page":"1269","volume":"143","author":"MF Weiner","year":"1996","unstructured":"Weiner MF, Risser RC, Cullum CM, et al.: Alzheimer\u2019s disease and its Lewy body variant: a clinical analysis of post-mortem verified cases. Am J Psychiatry 1996, 143:1269\u20131273.","journal-title":"Am J Psychiatry"},{"key":"13_CR4","first-page":"920","volume-title":"Handbuch der Neurologie","author":"FH Lewy","year":"1912","unstructured":"Lewy FH: Paralysis agitans, I: pathologische anatomie. In Handbuch der Neurologie. Edited by Lewandowsky M. Berlin: Springer; 1912:920\u2013933."},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00005072-196104000-00007","volume":"20","author":"H Okazaki","year":"1961","unstructured":"Okazaki H, Lipkin LE, Aronson SM: Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961, 20:237.","journal-title":"J Neuropathol Exp Neurol"},{"key":"13_CR6","first-page":"292","volume":"82","author":"K Kosaka","year":"1980","unstructured":"Kosaka K, Matsushita M, Oyanagi S, et al.: A clinicopathological study of the \"Lewy body disease.\" Psychiatr Neurol Jpn 1980, 82:292\u2013311.","journal-title":"Psychiatr Neurol Jpn"},{"key":"13_CR7","first-page":"2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, et al.: Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Nat Genet 1997, 276:2045\u20132047.","journal-title":"Nat Genet"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, et al.: Alphasynuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci 1998, 95:6469\u20136473.","journal-title":"Proc Natl Acad Sci"},{"key":"13_CR9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","volume":"58","author":"JE Galvin","year":"2001","unstructured":"Galvin JE, Lee MYL, Trojanowski JQ: Synucleinopathies. Arch Neurol 2001, 58:186\u2013190. Concise review of the synucleinopathies.","journal-title":"Arch Neurol"},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(99)90214-3","volume":"354","author":"IG McKeith","year":"1999","unstructured":"McKeith IG, O\u2019Brien JT, Ballard C: Diagnosing dementia with Lewy bodies. Lancet 1999, 354:1227\u20131228.","journal-title":"Lancet"},{"key":"13_CR11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.47.6.1403","volume":"47","author":"MS Mega","year":"1996","unstructured":"Mega MS, Masterman DL, Benson F, et al.: Dementia with Lewy bodies: reliability and validity of clinical and pathological criteria. Neurology 1996, 47:1403\u20131409.","journal-title":"Neurology"},{"key":"13_CR12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/(SICI)1099-1166(199907)14:7<526::AID-GPS965>3.0.CO;2-0","volume":"14","author":"CA Luis","year":"1999","unstructured":"Luis CA, Barker WW, Gajara K, et al.: Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry 1999, 14:526\u2013523.","journal-title":"Int J Geriatr Psychiatry"},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.174.1.45","volume":"174","author":"C Holmes","year":"1999","unstructured":"Holmes C, Cairns N, Lantos P, Mann A: Validity of current clinical criteria for Alzheimer\u2019s disease, vascular dementia, and dementia with Lewy bodies. Br J Psychiatry 1999, 174:45\u201350.","journal-title":"Br J Psychiatry"},{"key":"13_CR14","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/WNL.53.9.1974","volume":"53","author":"J Verghese","year":"1999","unstructured":"Verghese J, Crystal HA, Dickson DW, Lipton RB: Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 1999, 53:1974\u20131982.","journal-title":"Neurology"},{"key":"13_CR15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1099-1166(200005)15:5<387::AID-GPS131>3.0.CO;2-9","volume":"15","author":"IG McKeith","year":"2000","unstructured":"McKeith IG, Grace JB, Walker Z, et al.: Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. Int J Geriatr Psychiatry 2000, 15:387\u2013392.","journal-title":"Int J Geriatr Psychiatry"},{"key":"13_CR16","first-page":"283","volume":"53","author":"EJ Byrne","year":"1990","unstructured":"Byrne EJ, Lennox G, Lowe J, Reynolds G: Diffuse Lewy body disease: the clinical features. Adv Neurol 1990, 53:283\u2013286.","journal-title":"Adv Neurol"},{"key":"13_CR17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189.","journal-title":"J Psychiatr Res"},{"key":"13_CR18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, et al.: Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996, 47:1113\u20131124.","journal-title":"Neurology"},{"key":"13_CR19","first-page":"350","volume":"3","author":"A Sahgal","year":"1992","unstructured":"Sahgal A, Galloway PH, McKeith IG, et al.: A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types. Dementia 1992, 3:350\u2013354.","journal-title":"Dementia"},{"key":"13_CR20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1212\/WNL.46.3.682","volume":"46","author":"T Del-Ser","year":"1996","unstructured":"Del-Ser T, Munoz DG, Hachinski V: Temporal pattern of cognitive decline and incontinence is different in Alzheimer\u2019s disease and diffuse Lewy body disease. Neurology 1996, 46:682\u2013686.","journal-title":"Neurology"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/002383099200500108","volume":"5","author":"BF O\u2019Donnell","year":"1992","unstructured":"O\u2019Donnell BF, Drachman DA, Barnes HJ, et al.: Incontinence and troublesome behavior predict institutionalization in dementia. J Geriatr Psychiatry Neurol 1992, 5:45\u201352.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"13_CR22","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1212\/WNL.54.8.1616","volume":"54","author":"MP Walker","year":"2000","unstructured":"Walker MP, Ayre GA, Cummings JL, et al.: Quantifying fluctuations in dementia associated with Lewy bodies, Alzheimer\u2019s disease and vascular dementia. Neurology 2000, 54:1616\u20131624.","journal-title":"Neurology"},{"key":"13_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.66.3.401","volume":"66","author":"RCG Briel","year":"1999","unstructured":"Briel RCG, McKeith IG, Barker WA, et al.: EEG findings in dementia with Lewy bodies and Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatr 1999, 66:401\u2013403.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1212\/WNL.47.5.1148","volume":"47","author":"LA Klatka","year":"1996","unstructured":"Klatka LA, Louis ED, Schiffer RB: Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer\u2019s disease and Parkinson\u2019s disease comparison groups. Neurology 1996, 47:1148\u20131152.","journal-title":"Neurology"},{"key":"13_CR25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1176\/ajp.156.1.66","volume":"156","author":"C Ballard","year":"1999","unstructured":"Ballard C, Holmes C, McKeith I, et al.: Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer\u2019s disease. Am J Psychiatry 1999, 156:66\u201372.","journal-title":"Am J Psychiatry"},{"key":"13_CR26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mds.870100209","volume":"10","author":"ED Louis","year":"1995","unstructured":"Louis ED, Goldman JE, Powers JM, Fahn S: Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord 1995, 10:188\u2013194.","journal-title":"Mov Disord"},{"key":"13_CR27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1212\/WNL.48.2.376","volume":"48","author":"ED Louis","year":"1997","unstructured":"Louis ED, Klatka LA, Liu Y, Fahn S: Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson\u2019s disease. Neurology 1997, 48:376\u2013380.","journal-title":"Neurology"},{"key":"13_CR28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1212\/WNL.38.10.1520","volume":"38","author":"CR Burkhardt","year":"1998","unstructured":"Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, et al.: Diffuse Lewy body disease and progressive dementia. Neurology 1998, 38:1520\u20131528.","journal-title":"Neurology"},{"key":"13_CR29","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, et al.: Alphasynuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology 2000, 54:1916\u20131921.","journal-title":"Neurology"},{"key":"13_CR30","first-page":"311","volume":"69","author":"ED Louis","year":"1996","unstructured":"Louis ED, Fahn S: Pathologically diagnosed diffuse Lewy body disease: do the Parkinsonian features differ? Adv Neurol 1996, 69:311\u2013314.","journal-title":"Adv Neurol"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1212\/WNL.55.9.1401","volume":"55","author":"S Ha\u00efk","year":"2000","unstructured":"Ha\u00efk S, Brandel JP, Saxdovitch V, et al.: Dementia with Lewy bodies in a neuropathological series of suspected Creutzfeldt-Jakob disease. Neurology 2000, 55:1401\u20131404.","journal-title":"Neurology"},{"key":"13_CR32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","volume":"35","author":"IG McKeith","year":"1992","unstructured":"McKeith IG, Fairbain A, Perry R, et al.: Neuroleptic sensitivity in patients with senile dementia of the Lewy body type. BMJ 1992, 35:673\u2013678.","journal-title":"BMJ"},{"key":"13_CR33","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(05)78999-6","volume":"351","author":"C Ballard","year":"1998","unstructured":"Ballard C, Grace J, McKeith I, Holmes C: Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer\u2019s disease. Lancet 1998, 351:1032\u20131033.","journal-title":"Lancet"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0140-6736(95)92307-1","volume":"346","author":"IG McKeith","year":"1995","unstructured":"McKeith IG, Ballard CG, Harrison RWS: Neuroleptic sensitivity to risperidone in Lewy body dementia. Lancet 1995, 346:699.","journal-title":"Lancet"},{"key":"13_CR35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/(SICI)1099-1166(199906)14:6<459::AID-GPS957>3.0.CO;2-R","volume":"14","author":"Z Walker","year":"1999","unstructured":"Walker Z, Grace J, Overshot R, et al.: Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatr 1999, 14:459\u2013456.","journal-title":"Int J Geriatr Psychiatr"},{"key":"13_CR36","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0140-6736(94)90167-8","volume":"343","author":"MA Piggott","year":"1994","unstructured":"Piggott MA, Perry EK, McKeith IG, et al.: Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity. Lancet 1994, 343:1044\u20131045.","journal-title":"Lancet"},{"key":"13_CR37","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archneur.55.8.1132","volume":"55","author":"K Bashir","year":"1998","unstructured":"Bashir K, Elble RJ, Ghobrial M, Struble RG: Hemianopsia in dementia with Lewy bodies. Arch Neurol 1998, 55:1132\u20131135.","journal-title":"Arch Neurol"},{"key":"13_CR38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N","volume":"15","author":"RA Hauser","year":"2000","unstructured":"Hauser RA, Gauger L, Anderson WM, Zesiewicz TA: Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 2000, 15:658\u2013663. An excellent, important paper.","journal-title":"Mov Disord"},{"key":"13_CR39","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1212\/WNL.52.5.951","volume":"52","author":"TJ Ferman","year":"1999","unstructured":"Ferman TJ, Boeve BF, Smith GE: REM sleep behavior disorder and dementia: cognitive differences when compared to Alzheimer\u2019s disease. Neurology 1999, 52:951\u2013957.","journal-title":"Neurology"},{"key":"13_CR40","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1212\/WNL.46.2.388","volume":"46","author":"CH Schenk","year":"1996","unstructured":"Schenk CH, Bundlie SR, Mahowald MW: Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996, 46:388\u2013393.","journal-title":"Neurology"},{"key":"13_CR41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1212\/WNL.51.2.363","volume":"51","author":"BF Boeve","year":"1998","unstructured":"Boeve BF, Silber MH, Ferman TJ, et al.: REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 1998, 51:363\u2013370.","journal-title":"Neurology"},{"key":"13_CR42","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/WNL.55.11.1730","volume":"55","author":"RS Turner","year":"2000","unstructured":"Turner RS, Amato CJD, Chervin RD, Blaivas M: The pathology of REM sleep behavior disorder with comorbid Lewy body dementia. Neurology 2000, 55:1730\u20131732.","journal-title":"Neurology"},{"key":"13_CR43","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1212\/WNL.55.6.870","volume":"55","author":"JM Ringman","year":"2000","unstructured":"Ringman JM, Simmons JH: Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 2000, 55:870\u2013871.","journal-title":"Neurology"},{"key":"13_CR44","first-page":"464","volume":"60","author":"S Kuzuhara","year":"1993","unstructured":"Kuzuhara S, Yoshimura M: Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. Adv Neurol 1993, 60:464\u2013469.","journal-title":"Adv Neurol"},{"key":"13_CR45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George JM, Jin H, Woods WS, Clayton DF: Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 1995, 15:361\u2013372.","journal-title":"Neuron"},{"key":"13_CR46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(98)00856-8","volume":"258","author":"E Iseki","year":"1998","unstructured":"Iseki E, Marui W, Kosaka K, et al.: Degenerative terminals of the perforant pathway are human-\u03b1-synuclein-immunoreactivity in the hippocampus of patients with diffuse Lewy body disease. Neurosci Lett 1998, 258:81\u201384.","journal-title":"Neurosci Lett"},{"key":"13_CR47","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, et al.: Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: implications for neurodegenerative disorders. Science 2000, 287:1265\u20131269.","journal-title":"Science"},{"key":"13_CR48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2000.tb06902.x","volume":"920","author":"PJ Kahle","year":"2000","unstructured":"Kahle PJ, Neumann M, Ozmen L, Haass C: Physiology and pathophysiology of _-synuclein: cell culture and transgenic animal models based on a Parkinson\u2019s disease-associated protein. Ann N Y Acad Sci 2000, 920:33\u201338.","journal-title":"Ann N Y Acad Sci"},{"key":"13_CR49","first-page":"1995","volume":"79","author":"PL McGreer","year":"1987","unstructured":"McGreer PL, Itagaki S, Tago H, McGeer EG: Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatiblity glycoprotein HLA-DR. Neurosci Lett 1987, 79:1995\u2013200.","journal-title":"Neurosci Lett"},{"key":"13_CR50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.55.1.132","volume":"55","author":"IRA McKenzie","year":"2000","unstructured":"McKenzie IRA: Activated microglia in dementia with Lewy bodies. Neurology 2000, 55:132\u2013134.","journal-title":"Neurology"},{"key":"13_CR51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archneur.57.6.817","volume":"57","author":"CE Shepherd","year":"2000","unstructured":"Shepherd CE, Thiel E, McCann H, et al.: Cortical inflammation in Alheimer\u2019s disease but not dementia with Lewy bodies. Arch Neurol 2000, 57:817\u2013822.","journal-title":"Arch Neurol"},{"key":"13_CR52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1991.tb00217.x","volume":"640","author":"EK Perry","year":"1991","unstructured":"Perry EK, McKeith I, Thompsom P, et al.: Topograpy, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson\u2019s disease, and Alzheimer\u2019s disease. Ann N Y Acad Sci 1991, 640:197\u2013202.","journal-title":"Ann N Y Acad Sci"},{"key":"13_CR53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.67.2.209","volume":"67","author":"K Shiozaki","year":"1999","unstructured":"Shiozaki K, Iseki E, Uchiyama H, et al.: Alterations of muscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 1999, 67:209\u2013213.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13_CR54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/jnnp.68.2.253","volume":"68","author":"K Jellinger","year":"2000","unstructured":"Jellinger K: Alterations of muscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer\u2019s disease [letter]. J Neurol Neurosurg Psychiatry 2000, 68:243\u2013254.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13_CR55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.54.2.407","volume":"54","author":"P Tiraboschi","year":"2000","unstructured":"Tiraboschi P, Hansen LA, Alford M, et al.: Cholinergic dysfunction in diseases with Lewy bodies. Neurology 2000, 54:407\u2013411.","journal-title":"Neurology"},{"key":"13_CR56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0278-5846(98)00006-2","volume":"22","author":"K Ohara","year":"1998","unstructured":"Ohara K, Kondo N, Ohara K: Changes of monoamines in post-mortem brains from patients with diffuse Lewy body disease. Prog Neuro Biol Psychiatry 1998, 22:311\u2013317.","journal-title":"Prog Neuro Biol Psychiatry"},{"key":"13_CR57","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","volume":"122","author":"MA Piggott","year":"1999","unstructured":"Piggott MA, Marshall EF, Thomas N, et al.: Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer\u2019s disease and Parkinson\u2019s disease: rostrocaudal distribution. Brain 1999, 122:1449\u20131468.","journal-title":"Brain"},{"key":"13_CR58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.67.1.66","volume":"67","author":"R Barber","year":"1999","unstructured":"Barber R, Scheltens P, Gholkar A, et al.: White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer\u2019s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatr 1999, 67:66\u201372.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"13_CR59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7342","volume":"162","author":"M Higuchi","year":"2000","unstructured":"Higuchi M, Tashiro M, Arai H, et al.: Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol 2000, 162:247\u2013256.","journal-title":"Exp Neurol"},{"key":"13_CR60","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.47.2.462","volume":"47","author":"RL Albin","year":"1996","unstructured":"Albin RL, Minoshima S, D\u2019Amato CJ, et al.: Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 1996, 47:462\u2013466.","journal-title":"Neurology"},{"key":"13_CR61","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/WNL.55.10.1575","volume":"55","author":"XS Hu","year":"2000","unstructured":"Hu XS, Okamura N, Arai H, et al.: 18F-Fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology 2000, 55:1575\u20131577.","journal-title":"Neurology"},{"key":"13_CR62","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1212\/WNL.52.3.541","volume":"52","author":"NI Bohnen","year":"1999","unstructured":"Bohnen NI, Minoshima S, Giordani B, et al.: Motor correlates of occipital glucose hypometabolism in Parkinson\u2019s disease without dementia. Neurology 1999, 52:541.","journal-title":"Neurology"},{"key":"13_CR63","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.64.3.306","volume":"64","author":"PR Talbot","year":"1998","unstructured":"Talbot PR, Loyd JJ, Snowden JS, et al.: A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry 1998, 64:306\u2013313.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13_CR64","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.53.2.413","volume":"53","author":"K Ishii","year":"1999","unstructured":"Ishii K, Yamaji S, Kitagaki H, et al.: Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 1999, 53:413\u2013416.","journal-title":"Neurology"},{"key":"13_CR65","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1212\/WNL.56.5.643","volume":"56","author":"K Lobotesis","year":"2001","unstructured":"Lobotesis K, Fenwick JD, Phipps A, et al.: Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001, 56:643\u2013649.","journal-title":"Neurology"},{"key":"13_CR66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1041610298005341","volume":"10","author":"C Shea","year":"1998","unstructured":"Shea C, MacKnight C, Rockwood K: Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. Int Psychogeriatr 1998, 10:229\u2013238.","journal-title":"Int Psychogeriatr"},{"key":"13_CR67","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1212\/WNL.51.5.1512","volume":"51","author":"DI Kaufer","year":"1998","unstructured":"Kaufer DI, Catt KE, Lopez OL, DeKosky ST: Dementia with Lewy bodies: response to delerium-like features to donepezil. Neurology 1998, 51:1512.","journal-title":"Neurology"},{"key":"13_CR68","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/(SICI)1099-1166(199808)13:8<516::AID-GPS810>3.0.CO;2-O","volume":"13","author":"F Lebert","year":"1998","unstructured":"Lebert F, Pasquier F, Souliez L: Tacrine efficacy in Lewy body dementia. Int J Geriatr Psychiatry 1998, 13:516\u2013519.","journal-title":"Int J Geriatr Psychiatry"},{"key":"13_CR69","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(94)90966-0","volume":"343","author":"R Levy","year":"1994","unstructured":"Levy R, Eagger S, Griffiths M, et al.: Lewy bodies and response to tacrine in Alzheimer\u2019s disease. Lancet 1994, 343:176.","journal-title":"Lancet"},{"key":"13_CR70","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0140-6736(94)91933-X","volume":"344","author":"GK Wilcox","year":"1994","unstructured":"Wilcox GK, Scott MI: Tacrine for senile dementia of Alzheimer\u2019s of Lewy body type. Lancet 1994, 344:544.","journal-title":"Lancet"},{"key":"13_CR71","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","volume":"356","author":"I McKeith","year":"2000","unstructured":"McKeith I, Del Set T, Spano P, et al.: Efficacy of rivastigmine in dementia with Lewy body: a randomized, double-blind, placebo-controlled international study. Lancet 2000, 356:2031\u20132036. An important study that examines treatment with rivastigmine in Lewy body dementia.","journal-title":"Lancet"},{"key":"13_CR72","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1099-1166(200009)15:9<794::AID-GPS178>3.0.CO;2-1","volume":"15","author":"W Samuel","year":"2000","unstructured":"Samuel W, Caligirui M, Galasko D, et al.: Better cognitive performance and psychopathological response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry 2000, 15:794\u2013802.","journal-title":"Int J Geriatr Psychiatry"},{"key":"13_CR73","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/(SICI)1099-1166(200004)15:4<338::AID-GPS119>3.0.CO;2-U","volume":"15","author":"KL Lanctot","year":"2000","unstructured":"Lanctot KL, Hermann N: Donepezil for behavioural disorders associated with Lewy bodies: a case series. Int J Geriatr Psychiatry 2000, 15:338\u2013345.","journal-title":"Int J Geriatr Psychiatry"},{"key":"13_CR74","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000017260","volume":"11","author":"HW Querfurth","year":"2000","unstructured":"Querfurth HW, Allam GJ, Geffroy MA, et al.: Acetylcholinesterase inhibitors in dementia with Lewy bodies: results of a prospective pilot study. Dementia Geriatr Cogn Disord 2000, 11:314\u2013321.","journal-title":"Dementia Geriatr Cogn Disord"},{"key":"13_CR75","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/brain\/123.2.331","volume":"123","author":"EJ Olson","year":"2000","unstructured":"Olson EJ, Boeve BF, Silber MH: Rapid eye movement sleep behavior disorder: demographic, clinical, and laboratory findings in 93 cases. Brain 2000, 123:331\u2013339.","journal-title":"Brain"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-001-0013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-001-0013-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-001-0013-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:44Z","timestamp":1559437004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-001-0013-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s11940-001-0013-x","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}